R. Grunewald

Gemcitabine: metabolism, mechanisms of action, and self-potentiation.

V. Heinemann, W. Plunkett, P. Huang, 1995, Seminars in oncology.

Saturation of 2′, 2′-difluorodeoxycytidine 5′-triphosphate accumulation by mononuclear cells during a phase I trial of gemcitabine

J. Abbruzzese, W. Plunkett, P. Tarassoff, 2004, Cancer Chemotherapy and Pharmacology.

Pharmacologically directed design of the dose rate and schedule of 2',2'-difluorodeoxycytidine (Gemcitabine) administration in leukemia.

H. Kantarjian, J. Abbruzzese, W. Plunkett, 1990, Cancer research.

Gemcitabine for palliative treatment in metastatic breast cancer

K. Possinger, D. Lüftner, B. Flath, 1998, Journal of Cancer Research and Clinical Oncology.

A phase I clinical, plasma, and cellular pharmacology study of gemcitabine.

S. Mineishi, J. Abbruzzese, M. Raber, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Gemcitabine in leukemia: a phase I clinical, plasma, and cellular pharmacology study.

H. Kantarjian, W. Plunkett, K. Faucher, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II trial of gemcitabine in patients with pretreated advanced soft tissue sarcomas

K. Possinger, I. Genvresse, A. Dietzmann, 2000, Anti-cancer drugs.

[Post-remission treatment of acute leukemia in adulthood: allogeneic bone marrow transplantation or chemotherapy?].

U. Jehn, R. Grunewald, 1988, Klinische Wochenschrift.

Total lymphoid irradiation in multiple sclerosis.

G. Sawle, C. Wiles, A. Swan, 1994, Journal of neurology, neurosurgery, and psychiatry.

Effectiveness, safety and quality of life of trifluridine/tipiracil in pretreated patients with metastatic colorectal cancer: Real‐world data from the noninterventional TACTIC study in Germany

T. Decker, F. Hartmann, M. Welslau, 2023, International journal of cancer.